|
Clinical features
|
Primary infection
|
|---|
|
IM (n = 24)
|
Non-IM (n = 36)
|
|---|
|
Age (months)
|
47.8 ± 38.8
|
41.8 ± 32.3
|
|
Male/female patients
|
11/13
|
17/19
|
|
Length of stay (days)
|
11.0 ± 2.7*
|
9.1 ± 4.1
|
|
Fever
|
23 (95.8%)
|
31 (86.1%)
|
|
Cough
|
12 (50.0%)*
|
30 (83.3%)
|
|
Rash
|
4 (16.7%)
|
14 (38.9%)
|
|
Lymphadenopathy
|
20 (83.3%)*
|
11 (30. 6%)
|
|
Pharyngitis
|
23 (95.8%)*
|
26 (72.2%)
|
|
Palatal petechiae
|
13 (54.2%)*
|
3 (8.3%)
|
|
Abnormal chest X ray
|
6/7 (85.7%)*
|
7/20 (35.0%)
|
|
Hepatomegaly
|
11 (45.8%)*
|
0 (0.0%)
|
|
Splenomegaly
|
8 (33.3%)*
|
0 (0.0%)
|
|
ALC >10%
|
17/23 (73.9%)*
|
3/21 (14.3%)
|
|
Elevated ESR
|
11/20 (55.0%)
|
10/21 (47.6%)
|
|
Elevated CRP
|
9/19 (47.4%)
|
10/21 (47.6%)
|
|
ALF
|
13/18 (72.2%)*
|
4/18 (22.2%)
|
- IM, infectious mononucleosis; Non-IM, patients without IM; ALC, atypical lymphocytes; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; ALF, abnormal liver function (alanine aminotransferase or aspartate aminotransferase levels >46 U/L). *P < 0.05 versus the non-IM group.
